Clik here to view.
Clik here to view.
Novocure Receives Reimbursement Approval for Optune® in Japan for the...
ST. HELIER, Jersey Novocure (NASDAQ:NVCR) announced today that the Japanese Ministry of Health, Labour and Welfare has approved the recommendation by Japan’s Central Social Insurance Medical Council...
View ArticleClik here to view.
ノボキュア社、初発膠芽腫の治療を目的としたオプチューン日本における保険収載の承認を取得
ジャージー島セントヘリア （ビジネスワイヤ）– ノボキュア社（NASDAQ: NVCR）は本日、日本の厚生労働大臣が、中央社会保険医療協議会（中医協）の建議に基づき、初発膠芽腫の治療を目的としたオプチューンの保険収載を承認したと発表しました。...
View ArticleClik here to view.
武田任命Toshio Fujimoto, MD, MBA为湘南健康创新园区总经理
日本大阪 (美国商业资讯)–武田药品工业株式会社[TSE: 4502]今天宣布，Toshio Fujimoto, MD,...
View ArticleClik here to view.
Avita Announces New Chief Financial Officer; Existing CFO Moves to Chief...
VALENCIA, Calif. & PERTH, Australia & LONDON Avita Medical (ASX:AVH) (OTCQX:AVMXY), a regenerative medicine company with a technology platform positioned to address opportunities and unmet...
View ArticleClik here to view.
PMC Group International Announces Acquisition of Pharma Company in France
MOUNT LAUREL, N.J. PMC Group France, a wholly owned subsidiary of PMC Group International Inc., which is an independent arm of PMC Group Inc., announced the acquisition of the pharma business of...
View ArticleClik here to view.
Kubota Pharmaceutical Holdings Co., Ltd. Announces Intention to Terminate SEC...
SEATTLE Kubota Pharmaceutical Holdings Co., Ltd. (the “Company”) announces its intention to file Form 15F with the U.S. Securities and Exchange Commission (the “SEC”) to voluntarily terminate the...
View ArticleClik here to view.
Clik here to view.
PMC Group International宣布收购法国制药公司
新泽西州芒特劳雷尔 (美国商业资讯) — PMC Group Inc.的独立分支机构PMC Group International Inc.旗下的全资子公司PMC Group France宣布收购法国Isochem...
View ArticleClik here to view.
Uptick in M&A Activity and Investor Cash Expected to Re-Invigorate Pharma and...
LONDON & BOSTON & TOKYO & SAN FRANCISCO The upward momentum seen in the pharma and biotech sectors during 2017 looks set to continue into 2018, with more novel medicines set to hit the...
View ArticleClik here to view.
Rhythmlink Launches FDA Cleared MR Conditional*/CT Quick Connect System™...
COLUMBIA, S.C. Rhythmlink International, LLC has announced the release of a new product line designed to maximize efficiency and workflow when recording EEG on patients who require MR or CT imaging....
View ArticleClik here to view.
Orthocell Commences Treatment of Its 1,000th Patient
PERTH, Australia Regenerative medicine company Orthocell Limited (ASX:OCC, “Orthocell” or the “Company”) is pleased to announce that it has commenced treatment of its 1,000th patient, in its TGA...
View ArticleClik here to view.
Genentech’s HEMLIBRA (emicizumab-kxwh) Every Four Weeks Controlled Bleeds in...
SOUTH SAN FRANCISCO, Calif. Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive interim results from the Phase III HAVEN 4 study evaluating HEMLIBRA®...
View ArticleClik here to view.
Median Technologies Inks a Research Collaboration Agreement for Lung Cancer...
SOPHIA ANTIPOLIS, France Regulatory News: Median Technologies (Paris:ALMDT), The Imaging Phenomics Company® (Paris:ALMDT) announces today a research collaboration agreement with Xingtai People’s...
View ArticleClik here to view.
Takeda and Seattle Genetics to Present Positive Data from Phase 3 ECHELON-1...
CAMBRIDGE, Mass. & OSAKA, Japan & BOTHELL, Wash. Takeda Pharmaceutical Company Limited (TSE:4502) and Seattle Genetics, Inc. (NASDAQ: SGEN) today announced that data from the Phase 3...
View ArticleClik here to view.
ベルタンとザイモリサーチが新しい連携を発表
米カリフォルニア州アーバイン & メリーランド州ロックビル （ビジネスワイヤ） — ザイモリサーチ・コープとベルタンは、マイクロバイオームワークフローにおけるサンプル溶解処置を完全でバイアスのないものとする連携を発表します。ZymoBIOMICS®微生物叢標準品およびDNA精製用ZymoBIOMICS...
View ArticleClik here to view.
Bertin与Zymo Research宣布达成新的合作
加州尔湾和马里兰州罗克韦尔 (美国商业资讯) — Zymo Research Corp.与Bertin宣布一项合作，共同确保微生物圈工作流程中的样品溶解步骤完整无偏差。一份应用备注已经发布，其描述了材料、步骤和采用Precellys® Evolution...
View ArticleClik here to view.
ADC Therapeutics präsentiert Zwischenergebnisse aus Phase-I-Studie zu...
LAUSANNE, Schweiz ADC Therapeutics (ADCT), ein onkologisches Biotech-Unternehmen, das sich auf die Entwicklung von geschützten Antikörper-Wirkstoff-Konjugaten (Antibody Drug Conjugates, ADCs) zur...
View ArticleClik here to view.
Intercell USA Changes Name to Valneva USA, Inc. and Expands Commercial Presence
GAITHERSBURG, Md. Valneva SE, a fully integrated commercial stage biotech company focused on developing innovative, lifesaving vaccines, today announced that its subsidiary Intercell USA, Inc. has...
View ArticleClik here to view.
ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-301の第I相中間データを発表
スイス・ローザンヌ （ビジネスワイヤ） — 主要ながんを標的にした専有的な抗体薬物複合体（ADC）の開発を専門とするオンコロジー創薬／開発企業のADCセラピューティクス（ADCT）は本日、リンパ腫と白血病の重要な亜型でADCT-301（camidanlumab...
View Article